Buy Or Sell Opportunity • Jul 21
Now 35% undervalued after recent price drop Over the last 90 days, the stock has fallen 100% to €0.0005. The fair value is estimated to be €0.00077, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.5% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 9.5% in 2 years. Earnings are forecast to grow by 32% in the next 2 years. Upcoming Dividend • Jul 01
Upcoming dividend of R0.44 per share Eligible shareholders must have bought the stock before 08 July 2026. Payment date: 13 July 2026. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.7%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (3.0%). Announcement • Jun 20
Netcare Limited to Report Fiscal Year 2026 Results on Nov 23, 2026 Netcare Limited announced that they will report fiscal year 2026 results at 9:00 AM, South Africa Standard Time on Nov 23, 2026 Buy Or Sell Opportunity • Jun 17
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 99% to €0.01. The fair value is estimated to be €0.014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.5% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 9.2% in 2 years. Earnings are forecast to grow by 33% in the next 2 years. Reported Earnings • May 30
First half 2026 earnings released: EPS: R0.71 (vs R0.59 in 1H 2025) First half 2026 results: EPS: R0.71 (up from R0.59 in 1H 2025). Revenue: R13.3b (up 4.8% from 1H 2025). Net income: R841.0m (up 14% from 1H 2025). Profit margin: 6.3% (up from 5.8% in 1H 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Declared Dividend • May 27
First half dividend of R0.44 announced Shareholders will receive a dividend of R0.44. Ex-date: 8th July 2026 Payment date: 13th July 2026 Dividend yield will be 78%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (58% earnings payout ratio) and cash flows (76% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 45% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • Mar 24
Netcare Limited to Report First Half, 2026 Results on May 25, 2026 Netcare Limited announced that they will report first half, 2026 results on May 25, 2026 New Risk • Mar 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (50% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.7% average weekly change). Announcement • Jan 30
Ninety One SA (Pty) Ltd. acquired an additional 5.03% stake in Netcare Limited (JSE:NTC). Ninety One SA (Pty) Ltd. acquired an additional 5.03% stake in Netcare Limited (JSE:NTC) on January 29, 2026. Nedbank Corporate and Investment Banking acted as a sponsor in the transaction.
Ninety One SA (Pty) Ltd. completed the acquisition of an additional 5.03% stake in Netcare Limited (JSE:NTC) on January 29, 2026. Upcoming Dividend • Jan 14
Upcoming dividend of R0.49 per share Eligible shareholders must have bought the stock before 21 January 2026. Payment date: 26 January 2026. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 5.4%. Within top quartile of German dividend payers (4.5%). Higher than average of industry peers (2.4%). Announcement • Dec 19
Netcare Limited, Annual General Meeting, Feb 06, 2026 Netcare Limited, Annual General Meeting, Feb 06, 2026. Reported Earnings • Nov 25
Full year 2025 earnings released: EPS: R1.35 (vs R1.10 in FY 2024) Full year 2025 results: EPS: R1.35 (up from R1.10 in FY 2024). Revenue: R26.3b (up 4.5% from FY 2024). Net income: R1.74b (up 23% from FY 2024). Profit margin: 6.6% (up from 5.6% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. New Risk • Sep 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (52% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Announcement • Aug 09
Netcare Limited to Report Fiscal Year 2025 Results on Nov 24, 2025 Netcare Limited announced that they will report fiscal year 2025 results at 9:00 AM, South Africa Standard Time on Nov 24, 2025 Declared Dividend • May 21
First half dividend of R0.36 announced Shareholders will receive a dividend of R0.36. Ex-date: 9th July 2025 Payment date: 14th July 2025 Dividend yield will be 61%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (40% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 42% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • May 20
First half 2025 earnings released: EPS: R0.59 (vs R0.49 in 1H 2024) First half 2025 results: EPS: R0.59 (up from R0.49 in 1H 2024). Revenue: R12.7b (up 5.3% from 1H 2024). Net income: R739.0m (up 17% from 1H 2024). Profit margin: 5.8% (up from 5.3% in 1H 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Announcement • Mar 28
Netcare Limited to Report First Half, 2025 Results on May 19, 2025 Netcare Limited announced that they will report first half, 2025 results on May 19, 2025 Upcoming Dividend • Jan 15
Upcoming dividend of R0.40 per share Eligible shareholders must have bought the stock before 22 January 2025. Payment date: 27 January 2025. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.6%. Lower than top quartile of German dividend payers (4.9%). Higher than average of industry peers (2.6%). Announcement • Dec 18
Netcare Limited, Annual General Meeting, Feb 07, 2025 Netcare Limited, Annual General Meeting, Feb 07, 2025. Declared Dividend • Nov 27
Final dividend of R0.40 announced Shareholders will receive a dividend of R0.40. Ex-date: 22nd January 2025 Payment date: 27th January 2025 Dividend yield will be 60%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (73% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 39% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Nov 26
Full year 2024 earnings released: EPS: R1.10 (vs R0.94 in FY 2023) Full year 2024 results: EPS: R1.10 (up from R0.94 in FY 2023). Revenue: R25.2b (up 6.3% from FY 2023). Net income: R1.50b (up 19% from FY 2023). Profit margin: 5.9% (up from 5.3% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. New Risk • Nov 25
New major risk - Revenue and earnings growth Earnings have declined by 6.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.8% per year over the past 5 years. Minor Risks High level of debt (52% net debt to equity). Dividend is not well covered by cash flows (165% cash payout ratio). Announcement • Jul 30
Netcare Limited Announces Board and Committee Changes Netcare Limited announced that Mr. Mark Bower has notified the board of directors (‘Board’) of his intention to retire as Netcare's Chairperson, with effect from 30 September 2024. Consequently, Mr. Bower will also step down as Chairperson of the Nomination Committee, and as a member of the Audit, Risk, Remuneration and Social and Ethics Committees respectively, also with effect from the same date. Mr. Bower joined the Netcare Board as an independent non-executive director in November 2015 and was appointed Chairperson effective 1 January 2023. Shareholders are further advised that Mr. Alex Maditse, currently an independent non- executive director, has been appointed as the lead independent director. Mr. Maditse, who joined the Netcare Board in June 2023, has made significant contributions to the Group with his extensive business acumen and expertise. Netcare is confident in his ability to effectively lead the Board during this interim period. To ensure that the Audit Committee remains validly constituted, Mr. Ian Kirk, an independent non-executive director of the Board, has been appointed as a member of the Audit Committee, effective 30 September 2024. A further announcement will be made in due course with regard to the appointment of a new chairperson, as well as the reconstituted Board committees. Upcoming Dividend • Jul 05
Upcoming dividend of R0.30 per share Eligible shareholders must have bought the stock before 10 July 2024. Payment date: 15 July 2024. Payout ratio is a comfortable 66% but the company is paying out more than the cash it is generating. Trailing yield: 5.5%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (3.2%). New Risk • May 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks High level of debt (52% net debt to equity). Dividend is not well covered by cash flows (194% cash payout ratio). New Risk • Apr 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.8% average weekly change). Minor Risks High level of debt (45% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Announcement • Mar 05
Netcare Limited to Report First Half, 2024 Results on May 20, 2024 Netcare Limited announced that they will report first half, 2024 results on May 20, 2024 New Risk • Mar 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.8% average weekly change). Minor Risks High level of debt (45% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Buy Or Sell Opportunity • Jan 24
Now 29% undervalued The stock has been flat over the last 90 days, currently trading at €0.61. The fair value is estimated to be €0.86, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.4% over the last 3 years. Earnings per share has grown by 47%. For the next 3 years, revenue is forecast to grow by 6.7% per annum. Earnings are also forecast to grow by 20% per annum over the same time period. New Risk • Jan 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (45% net debt to equity). High level of debt (45% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.7% average weekly change). Upcoming Dividend • Jan 17
Upcoming dividend of R0.35 per share at 5.0% yield Eligible shareholders must have bought the stock before 24 January 2024. Payment date: 29 January 2024. Payout ratio is a comfortable 69% and this is well supported by cash flows. Trailing yield: 5.0%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.3%). Announcement • Dec 19
Netcare Limited, Annual General Meeting, Feb 02, 2024 Netcare Limited, Annual General Meeting, Feb 02, 2024, at 10:00 South Africa Standard Time. Agenda: To consider re-election and election of directors; to consider re-appointment of independent external auditors; to consider appointment of audit committee members; to consider signature of documents; to consider approval of the remuneration policy; to consider approval of the implementation report; to consider general authority to repurchase shares; and to consider other matters. Announcement • Nov 15
Netcare Limited Provides Earnings Guidance for the Year Ended 30 September 2023 Netcare Limited provided earnings guidance for the year ended 30 September 2023. For the year, the company expected earnings per share (EPS) of 93.3 cents to 95.4 cents; headline earnings per share (HEPS) of 99.9 cents to 102.1 cents. Announcement • Sep 29
Netcare Limited to Report Fiscal Year 2023 Results on Nov 20, 2023 Netcare Limited announced that they will report fiscal year 2023 results on Nov 20, 2023 Announcement • Sep 18
Netcare Limited(JSE:NTC) dropped from FTSE All-World Index (USD) Netcare Limited(JSE:NTC) dropped from FTSE All-World Index (USD) Upcoming Dividend • Jul 05
Upcoming dividend of R0.30 per share at 4.2% yield Eligible shareholders must have bought the stock before 12 July 2023. Payment date: 17 July 2023. Payout ratio is a comfortable 68% and this is well supported by cash flows. Trailing yield: 4.2%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.1%). Announcement • Jun 08
Netcare Limited Announces Change to the Board of Directors Netcare Limited announce the appointment of Mr. Alex Maditsi as an independent non-executive director to the Board of Netcare ("Board") with effect from 7 June 2023. Mr. Maditsi has also been appointed to the Board Social and Ethics and Board Consistency of Care Committees. He obtained a Bachelor of Law degree from the University of Witwatersrand and holds LLMs degrees from the University of Pennsylvania and Harvard University of Law, respectively. He is the managing director of Copper Moon Trading, with over 25 years of professional experience across the globe, and has served as chairperson of the social and ethics committee of Famous Brands Limited and as a member of the remuneration committee for Murray & Roberts Holdings Limited. Furthermore, Mr. Maditsi is currently the lead independent director for African Rainbow Minerals Limited. Reported Earnings • May 22
First half 2023 earnings released: EPS: R0.46 (vs R0.31 in 1H 2022) First half 2023 results: EPS: R0.46 (up from R0.31 in 1H 2022). Revenue: R11.5b (up 12% from 1H 2022). Net income: R641.0m (up 55% from 1H 2022). Profit margin: 5.6% (up from 4.0% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • May 22
Netcare Limited Announces Interim Dividend in Respect of the Period Ended 31 March 2023, Payable on 17 July 2023 Netcare Limited announced the declaration of a gross interim dividend of 30.0 cents per ordinary share in respect of the period ended 31 March 2023. The dividend has been declared from income reserves and is payable to shareholders recorded in the register at the close of business on 14 July 2023. The number of ordinary shares (inclusive of treasury shares) in issue at the date of this declaration is 1 439 090 009. The dividends will be subject to a local dividend withholding tax at a rate of 20%, which will result in a net final dividend to those shareholders not exempt from paying dividend withholding tax of 24.0 cents per ordinary share and 30.0 cents per ordinary share for those shareholders who are exempt from dividend withholding tax. The Board has confirmed by resolution that the solvency and liquidity test as contemplated by the Companies Act 71 of 2008 has been duly considered, applied and satisfied. Trading ex-dividend commences, 12 July 2023. Record date is 14 July 2023. Payment date is 17 July 2023. Last day to trade cum dividend is 11 July 2023. Announcement • May 19
Netcare Limited Provides Group Earnings Guidance for the Six Months Ended 31 March 2023 Netcare Limited Provided Group Earnings Guidance for the Six Months Ended 31 March 2023. For the period, the company expects EPS to be in the range of 45.6 cents to 46.1 cents. Buying Opportunity • May 16
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 1.1%. The fair value is estimated to be €0.86, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 43%. For the next 3 years, revenue is forecast to grow by 7.4% per annum. Earnings is also forecast to grow by 26% per annum over the same time period. Announcement • Feb 10
Netcare Limited to Report First Half, 2023 Results on May 22, 2023 Netcare Limited announced that they will report first half, 2023 results on May 22, 2023 Announcement • Feb 04
Netcare Limited Approves Audit Committee Changes Netcare Limited at annual general meeting held on 3 February 2023, approved the appointment of audit committee as follows: M Bower (Member), B Bulo (Chair), T Leoka (Member) and L Stephens (Member). Upcoming Dividend • Jan 18
Upcoming dividend of R0.30 per share Eligible shareholders must have bought the stock before 25 January 2023. Payment date: 30 January 2023. Payout ratio is a comfortable 69% and this is well supported by cash flows. Trailing yield: 4.0%. Lower than top quartile of German dividend payers (4.6%). Higher than average of industry peers (3.6%). Announcement • Dec 16
Netcare Limited, Annual General Meeting, Feb 03, 2023 Netcare Limited, Annual General Meeting, Feb 03, 2023, at 10:00 South Africa Standard Time. Buying Opportunity • Dec 02
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 9.3%. The fair value is estimated to be €0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 43%. For the next 3 years, revenue is forecast to grow by 7.4% per annum. Earnings is also forecast to grow by 26% per annum over the same time period. Buying Opportunity • Nov 03
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 6.2%. The fair value is estimated to be €0.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 58%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 117% in the next 2 years. Upcoming Dividend • Jun 29
Upcoming dividend of R0.20 per share Eligible shareholders must have bought the stock before 06 July 2022. Payment date: 11 July 2022. Payout ratio is on the higher end at 91%, however this is supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of German dividend payers (4.5%). In line with average of industry peers (3.0%). Reported Earnings • May 27
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down R351.0m from profit in 1H 2021). Profit margin: (down from 3.5% in 1H 2021). The decrease in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 8.5%, compared to a 5.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improved over the past week After last week's 22% share price gain to €1.04, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 17x in the Healthcare industry in Germany. Total loss to shareholders of 16% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €2.01 per share. Upcoming Dividend • Jan 19
Upcoming dividend of R0.34 per share Eligible shareholders must have bought the stock before 26 January 2022. Payment date: 31 January 2022. Payout ratio is a comfortable 62% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (3.3%). In line with average of industry peers (2.4%). Reported Earnings • Nov 24
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: R0.55 (up from R0.28 in FY 2020). Revenue: R21.2b (up 13% from FY 2020). Net income: R730.0m (up 93% from FY 2020). Profit margin: 3.4% (up from 2.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 9.7%, compared to a 4.0% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Reported Earnings • May 27
First half 2021 earnings released: EPS R0.26 (vs R0.44 in 1H 2020) The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: R10.1b (down 5.9% from 1H 2020). Net income: R351.0m (down 40% from 1H 2020). Profit margin: 3.5% (down from 5.4% in 1H 2020). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 06
New 90-day high: €0.82 The company is up 17% from its price of €0.70 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is down 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.13 per share. Reported Earnings • Nov 25
Full year 2020 earnings released: EPS R0.28 The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: R18.8b (down 13% from FY 2019). Net income: R392.0m (down 84% from FY 2019). Profit margin: 2.1% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Nov 25
Revenue misses expectations Revenue missed analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 16%, compared to a 4.2% growth forecast for the Healthcare industry in Germany. Is New 90 Day High Low • Oct 27
New 90-day high: €0.71 The company is up 3.0% from its price of €0.69 on 29 July 2020. The German market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is down 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €0.94 per share. Is New 90 Day High Low • Sep 22
New 90-day low: €0.58 The company is down 11% from its price of €0.66 on 24 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is down 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €0.92 per share. 
